Stock News
Get Ready to Roll: Instacart and Coles Supermarkets Team Up to Bring Smart Trolleys to Australia!
Coles Supermarkets Introduces AI-Powered Smart Trolleys to Melbourne Joining Forces with Instacart to Revolutionize Shopping Experience MELBOURNE, Australia – Nov. 12, 2024 – Coles Supermarkets, a household name in Australia, is set to transform the way customers shop with the introduction of Caper Carts, Instacart’s AI-powered smart trolleys. This innovative partnership between Coles Supermarkets and…
Breaking News: Moleculin Receives Institutional Review Board Approval for Groundbreaking Phase 3 Trial of Annamycin and Cytarabine in Treating RR Acute Myeloid Leukemia (AML)
Exciting News in Cancer Treatment Company Leading the Way in AML Trials Recently, Moleculin Biotech, Inc. announced that it is on track to treat the first subject in its pivotal Phase 3 clinical trial in early 2025. This trial, known as the “MIRACLE” trial, is designed to potentially accelerate the approval of Annamycin in combination…
SP Global Unveils New AI-Powered Capabilities for Enhanced SP Capital IQ Pro Experience
Charmingly Eccentric Document Intelligence and ChatIQ Enhance S&P Capital IQ Pro for Maximum Reader Engagement Exciting news has just been announced by S&P Global, a leading financial information and analytics company. S&P Global has introduced groundbreaking generative-AI (GenAI) enhancements to its S&P Capital IQ Pro platform. These enhancements include the innovative technologies of Document Intelligence…
Revolutionizing Healthcare: First Patient Enrollments Mark Major Milestone for Innovative Medical Technology
The Future of Medical Technology: A Breakthrough in Trials Vancouver, Kelowna, and Delta, British Columbia–(Newsfile Corp. – November 12, 2024) – Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical technology as first patients are enrolled in potential breakthrough trials, featuring Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic…
Breaking Down the Numbers: Heron Therapeutics’ Third Quarter 2024 Financial Results and Updated Guidance
Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million – $43 million ZYNRELEF® (bupivacaine and meloxicam) extended-release solution Vial Access Needle (“VAN”) approved in September and on track for Q4 2024 launch CMS Final Rule Non-Opioid Policy for Pain Relief includes ZYNRELEF as…
Echostar Corporation Successfully Completes Strategic Transactions to Enhance Nationwide Open RAN 5G Network
EchoStar’s Strategic Transactions Positioning It for Nationwide Open RAN 5G Network Enhancement Highlighting the Value of EchoStar’s Spectrum Assets EchoStar’s recent transactions underscore the tremendous value of its spectrum assets, providing a sturdy platform for the company to accelerate the deployment of a nationwide wireless service. This move is aimed at intensifying competition with existing…
Get Ready to Party: Sphere Entertainment Co. Crushes First Quarter Earnings in 2025!
Welcome to the Sphere Experience! Financial Update: Sphere Entertainment Co. Q1 2024 Results NEW YORK, Nov. 12, 2024 /PRNewswire/ — Sphere Entertainment Co. (NYSE: SPHR) (“Sphere Entertainment” or the “Company”) today reported financial results for the fiscal first quarter ended September 30, 2024. Recent Sphere operating highlights include: Exciting Developments In October, the Company and…
Ondas Holdings Soars: A Look at Their Third Quarter 2024 Financial Report and $144 Million in Drone Platform Purchase Orders!
Ondas Holdings Inc. Reports Record Bookings in Q3 Iron Drone Raider and Optimus System Stand Out In a major milestone for Ondas Holdings Inc., the company announced its largest bookings in history during Q3, totaling $14.4 million in purchase orders. The majority of these orders came from a significant military customer for the Iron Drone…